Acta Scientific Microbiology (ISSN: 2581-3226)

Editorial Volume 4 Issue 9

Comparative Characteristics of the Main Coronavirus Vaccines

Pavel F Zabrodskii*

Saratov Medical University "REAVIZ", Saratov, Russian Federation

*Corresponding Author: Pavel F Zabrodskii, Saratov Medical University "REAVIZ", Saratov, Russian Federation.

Received: June 23, 2021 ; Published: August 01, 2021

Since the beginning of the epidemic, vaccine development has been a priority for all developed countries. According to WHO (26 January 2021), more than 60 vaccines worldwide are already in clinical trials. More than 170 are being tested on animals. There are 22 vaccines that have made it through the final phase of testing.

Citation

Citation: Pavel F Zabrodskii. “Comparative Characteristics of the Main Coronavirus Vaccines ”. Acta Scientific Microbiology 4.9 (2021): 01-02.

Copyright

Copyright: © 2021 Pavel F Zabrodskii. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate33%
Acceptance to publication20-30 days
Impact Factor0.810

Indexed In



News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is October 20, 2021.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of “Best Article of the Issue”.
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.
  • Contact US